News

The registration, which was filed under InB: Hauser Pharmaceutical Services, will now allow the firm to immediately manufacture schedule II-V compounds. With the new DEA registration status CHO

ClinStar provides Phase I-IV clinical research trials and clinical development services to a wide range of pharmaceutical and biotechnology companies in the Russian Federation, Ukraine, Belarus and the

Taiho is seeking approval of TAS-102 for the indication of unresectable, advanced, recurrent colorectal cancer. The application is based on the results of a Phase II clinical trial

Both the firms, which have been working together since 2007, have created a lean supply chain, prior to which the pharmaceutical firm’s manufacturing plants operated independently and managed

In February 2012, IDT and SGI began to co-manufacture and commercialize small synthetic gene products up to 5 kb, while IDT has also launched its gBlocks Gene Fragments

Created using patent-pending Cunermuspir complex, the new supplement supports optimum neuromuscular health and provides energy. Cunermuspir Complex helps to improve the body’s ability to absorb copper to support

Using the company’s novel and proprietary monomeric Fc fusion technology, clotting factor rFIXFc provides long-lasting protection from bleeding and reduces the treatment burden associated with hemophilia B. The

The small molecule therapeutic, which has dual mode of action including anti-catabolic and pro-anabolic activity, is indicated for the treatment of cancer cachexia, a wasting syndrome characterized by

The collaboration was formed to discover novel small molecules for an undisclosed target using Vernalis’ fragment and structure-based drug discovery technology. Vernalis said the final payment is in